DiabetaCare Opportunity DiabetaCare launch in November 2024 indicates active expansion into chronic disease management products. Sales teams can target healthcare providers, pharmacies, and corporate wellness programs in Indonesia, emphasizing diabetes support and integration with Kalbe’s nutrition portfolio.

Entrasol Can Expansion Introduction of Entrasol Can Susu Steril in June 2024 expands ready-to-drink and convenient nutrition formats. Leverage this as a cross-sell opportunity to retailers and on-the-go segments, targeting busy professionals and modern retail channels.

Strong Brand Backbone As a division of PT Kalbe Farma Tbk, Kalbe Nutritionals benefits from an established pharmaceutical and health foods reputation. Use this credibility in B2B pitches to institutions, hospitals, and corporate wellness programs seeking trusted nutrition solutions.

Digital Analytics Ready Utilization of Looker, Power BI, Tableau, and AWS indicates data-driven decision making. Propose data-backed marketing and sales collaborations, such as co-branded health programs and performance reporting for retail partners.

Mid-market Scale Leverage Revenue range of $100M-$250M and a workforce of 1000–5000 positions Kalbe Nutritionals as a mid-market player. Target mid-size distributors, regional retailers, and private-label opportunities to accelerate channel expansion and geographic reach.